HomeNewsIndiaOxygen supplies run low as India grapples with coronavirus "storm"

Oxygen supplies run low as India grapples with coronavirus "storm"

India, the world's second most populous country, is reporting the world's highest number of new daily cases and approaching a peak of about 297,000 cases in one day that the United States hit in January.

April 21, 2021 / 09:32 IST
Story continues below Advertisement
Hospitals are running short of oxygen and widely prescribed medicines such as Remdesivir and Fabiflu, prompting desperate people to pay exorbitant black market rates. Social media is full of horror stories of desperate calls to help a loved one needing hospital treatment for Covid-19 or other complaints. (Image: AFP)
Hospitals are running short of oxygen and widely prescribed medicines such as Remdesivir and Fabiflu, prompting desperate people to pay exorbitant black market rates. Social media is full of horror stories of desperate calls to help a loved one needing hospital treatment for Covid-19 or other complaints. (Image: AFP)

Indian authorities scrambled to shore up supplies of medical oxygen to hospitals in the capital, Delhi, on Wednesday as a fast-spreading second wave of coronavirus stretched medical infrastructure to breaking point, officials and doctors said.

India, the world's second most populous country, is reporting the world's highest number of new daily cases and approaching a peak of about 297,000 cases in one day that the United States hit in January.

Story continues below Advertisement

Delhi's government issued a call for help on social media saying major government hospitals only had enough oxygen to last another eight to 24 hours while some private ones had enough for just four or five hours.

One hospital, the GTB hospital, got some oxygen supplies just before it was going to run out of stocks for its 500 patients, media reported.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show